Literature DB >> 24380699

Monoclonal antibody binding-site diversity assessment with a cell-based clustering assay.

Sindy Liao-Chan1, Joseph Zachwieja2, Steven Gomez3, Dana Duey4, John Lippincott5, Jan-Willem Theunissen6.   

Abstract

The diversity of a panel of antibodies that target a specific antigen can be established in various assay formats. In conventional epitope binning assays purified antibodies are tested in a pairwise manner: two antibodies that compete with each other for binding to an antigen are grouped into the same cluster or bin, while they are assigned to two different clusters when they do not compete. Here we present a high through put assay that enables grouping of crude hybridoma supernatants without a need for antibody purification. In addition, the assay does not require recombinant protein, because it is conducted on cells that express the antigen of interest. Hence, one can use the antibody-clustering assay for cell surface proteins that are not amenable to purification. Heavy chain variable region (VH) sequencing shows that VH composition within clusters is conserved. Finally, the assay is in good agreement with a conventional epitope binning assay with purified antigen.
Copyright © 2013 Elsevier B.V. All rights reserved.

Keywords:  Antibody sequencing; Biosensor; Clustering assay; Engineered cell lines; Epitope binning; Monoclonal antibody

Mesh:

Substances:

Year:  2013        PMID: 24380699     DOI: 10.1016/j.jim.2013.12.007

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  CD39 is a promising therapeutic antibody target for the treatment of soft tissue sarcoma.

Authors:  Gregory M Hayes; Belinda Cairns; Zoia Levashova; Lawrence Chinn; Myra Perez; Jan-Willem Theunissen; Sindy Liao-Chan; Abel Bermudez; Mark R Flory; Karl J Schweighofer; Edward H van der Horst
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

2.  Quantitative assessment of antibody internalization with novel monoclonal antibodies against Alexa fluorophores.

Authors:  Sindy Liao-Chan; Barbara Daine-Matsuoka; Nathan Heald; Tiffany Wong; Tracey Lin; Allen G Cai; Michelle Lai; Joseph A D'Alessio; Jan-Willem Theunissen
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

3.  Generation of a highly diverse panel of antagonistic chicken monoclonal antibodies against the GIP receptor.

Authors:  Jennifer D Könitzer; Shreya Pramanick; Qi Pan; Robert Augustin; Sebastian Bandholtz; William Harriman; Shelley Izquierdo
Journal:  MAbs       Date:  2017-01-05       Impact factor: 5.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.